PD-L1 upregulation can be motivated by cytokines induced by tumor-infiltrating immune cells, including interferon (IFN), tumor necrosis factor (TNFalpha), interleukin (IL-4), and vascular endothelial growth factor (VEGF) etc. [31–34]. Here, IL4 is linked to neoplasm.